Microbicidal, prophylactic and therapeutic effect of CTC-96 on papilloma viruses

Details for Australian Patent Application No. 2004249292 (hide)

Owner Redox Pharmaceutical Corporation Audubon Biomedical Science and Technology Park

Inventors Gershon, David

Agent Mallesons

Pub. Number AU-A-2004249292

PCT Pub. Number WO2004/112722

Priority 60/480,206 20.06.03 US

Filing date 21 June 2004

Wipo publication date 29 December 2004

International Classifications

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

Event Publications

22 December 2005 PCT application entered the National Phase

  PCT publication WO2004/112722 Priority application(s): WO2004/112722

10 April 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004249295-Compositions for and methods for treating HIV

2004249291-Device and method for delivering an implant through an annular defect in an intervertebral disc